Rankings
▼
Calendar
ARGX Q4 2022 Earnings — argenx SE Revenue & Financial Results | Market Cap Arena
ARGX
argenx SE
$46B
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$303M
+1063.3% YoY
Gross Profit
-$78M
-25.6% margin
Operating Income
-$302M
-99.6% margin
Net Income
-$256M
-84.4% margin
EPS (Diluted)
$-4.62
Cash Flow
Operating Cash Flow
-$344M
Free Cash Flow
-$345M
Stock-Based Comp.
$75M
Balance Sheet
Total Assets
$3.1B
Total Liabilities
$321M
Stockholders' Equity
$2.8B
Cash & Equivalents
$801M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$303M
$26M
+1063.3%
Gross Profit
-$78M
-$243M
+68.1%
Operating Income
-$302M
-$390M
+22.6%
Net Income
-$256M
-$414M
+38.3%
← FY 2022
All Quarters
Q1 2023 →